Pointe Capital Management LLC Johnson & Johnson Transaction History

Pointe Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $113,853 - $127,544	-731 Reduced 27.02%	1,974 $307,000
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $14,508 - $15,614	94 Added 3.6%	2,705 $447,000
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $50,752 - $60,567	336 Added 14.77%	2,611 $404,000
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $60,074 - $67,421	-375 Reduced 14.15%	2,275 $402,000
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $19,491 - $21,626	-125 Reduced 4.5%	2,650 $453,000
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $127,583 - $136,856	800 Added 40.51%	2,775 $457,000
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $9,031 - $10,058	59 Added 3.08%	1,975 $325,000
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $6,036 - $6,614	43 Added 2.3%	1,916 $285,000
Q3 2017 Oct 16, 2017	BUY	$129.47 - $135.38 $242,497 - $253,566	1,873	1,873 $244,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pointe Capital Management LLC with notifications on news.